FDA Adverse Event Injury Summary report: N

OMNIPOD INSULIN PUMP

MDR report key: 23081794 · Received September 18, 2025

Report

Report Number
3004464228-2025-42598
Event Type
Injury
Date Received
September 18, 2025
Date of Event
September 6, 2025
Report Date
September 18, 2025
Manufacturer
INSULET CORPORATION
Product Code
LZG
PMA / PMN Number
K211575
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 0

THE DEVICE HAS NOT BEEN RETURNED/RECEIVED TO DATE. IF THE DEVICE IS RECEIVED, A SUPPLEMENTAL REPORT WILL BE SUBMITTED WITH THE INVESTIGATION RESULTS. WE ARE UNABLE TO DETERMINE IF ANY PRODUCT CONDITION COULD HAVE CONTRIBUTED TO THE REPORTED HOSPITALIZATION AND DIABETIC KETOACIDOSIS. LOT RELEASE RECORDS WERE REVIEWED AND THE PRODUCT LOT MET ALL ACCEPTANCE CRITERIA. SPECIFICALLY, A POD IS PAIRED TO A PDM AND PUT THROUGH SIMULATED USE TESTING INCLUDING COMMUNICATING WITH THE PDM, DEPLOYMENT, DELIVERING FLUID, OCCLUSION DETECTION, AND FREEDOM FROM HAZARD ALARMS.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT HAD BEEN HOSPITALIZED WITH DIABETIC KETOACIDOSIS (DKA) ON (B)(6) 2025. THE PATIENT'S BLOOD GLUCOSE LEVELS REACHED 30.2 MMOL/L (544 MG/DL) WHILE WEARING THE POD BETWEEN 4 AND 24 HOURS. SYMPTOMS REPORTED INCLUDE HYPERGLYCEMIA, CHEST PAIN, DEHYDRATED LIPS, BLOOD PRESSURE OF 153/119 AND HEART RATE OF 127 BEATS PER MINUTE. THE PATIENT WAS TREATED WITH INSULIN, DEXTROSE, SALINE SOLUTION, AND RINGER LACTATE (DOSES, FREQUENCY, AND ROUTES WERE NOT SPECIFIED). IT WAS UNSPECIFIED WHEN THE POD WAS REMOVED BUT IT WAS FOUND TO BE LEAKING INSULIN. A NEW POD WAS SUCCESSFULLY PLACED PRIOR TO THE PATIENT LEAVING THE HOSPITAL. THE PATIENT WAS RELEASED THE FOLLOWING DAY (B)(6) 2025.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1705711 OMNIPOD INSULIN PUMP PUMP, INFUSION, INSULIN LZG INSULET CORPORATION 40160 L72516

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown Hospitalization